bioRxivNeurosciencePreprint
Regional patterns of neurodegeneration in a mouse model of proteinopathy
Dmytro ShepiloviD, Ibrahim Ahmed KhaniD, Hsiao‐Jou Cortina CheniD, Ália dos SantosiD, Christine RowleyiD, Edward C. HardingiD, Florian T. MerkleiD, Sneak Peek Administrator
Abstract
The aggregation of misfolded proteins is a hallmark of many neurodegenerative diseases, suggesting shared pathological mechanisms. However, the pathways by which protein misfolding in these proteinopathies lead to neuronal death remain unclear. Proteinopathies can be modelled in transgenic animals by expressing disease-causing mutations that promote protein aggregation, or in wild-type animals by injecting misfolded proteins (e.g. RML scrapie) that spread in a prion-like manner and recapitulate key neurodegenerative features, including gliosis, ER stress, and neuronal loss. Here, we map region-specific histopathological features of scrapie-induced neurodegeneration in the hippocampus, thalamus, cortex, and cerebellum during early (12 weeks post-inoculation) and late (20 weeks) stages of disease. Using a streamlined time-efficient protocol, we achieve reproducible paired sample collection and high-quality immunohistochemistry that is compatible with best practice in decontamination and containment. We found that among the tested markers of early pathology, thalamic astrocytic activation and spongiform degeneration were the most sensitive. By the late stage, there was widespread upregulation of IBA1+ microglia and GFAP+ astrocytes, accompanied by strong immunoreactivity of lysosomal marker LAMP1. LAMP1 expression in healthy brains was largely neuronal, but by 20 weeks it was significantly upregulated in astrocytes, suggesting their involvement in lysosomal pathology. The ER stress marker p-PERK was elevated in CA1/CA3 pyramidal neurons but minimal in the thalamus and cerebellum, where neuronal loss was most pronounced, suggesting region-specific mechanisms of degeneration. Overall, the thalamus and hippocampal CA1/CA3 areas exhibited the greatest pathological burden. Our shorter time-course, new pathological insights and safe handling protocols, and improved welfare, supports broader adoption of the RML scrapie model for resource-efficient studies of neurodegeneration and its prevention.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of region-specific glial homeostatic signature in prion diseases
Natallia Makarava, Jennifer C. Chang, … Ilia V. Baskakov·bioRxiv·Oct 30, 2019
- Simultaneous pathway engagement of translation in astrocytes, circadian rhythm in GABAergic neurons and cytoskeleton in glutamatergic neurons precede electroencephalographic changes in neurodegenerative prion disease
Lech Kaczmarczyk, Melvin Schleif, … Walker S. Jackson·PLoS PathogensPeer-reviewed·Aug 12, 2022
- Neurodegeneration and neuroinflammation are linked, but independent of alpha-synuclein inclusions, in a seeding/spreading mouse model of Parkinson disease
Pierre Garcia, Wiebke M. Wemheuer, … Manuel Buttini·bioRxiv·Aug 5, 2020
- Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome
Sveva Fornari, Amelie Schäfer, … Alain Goriely·Journal of Theoretical BiologyPeer-reviewed·Dec 3, 2019
- Therapeutic window for treatment of prion disease defined by timed depletion of Prion protein
Barry Matthew Bradford, Alison Marshall, … Jean C. Manson·bioRxiv·Nov 18, 2024
- Protein folding stress shapes microglial phenotype in progressive supranuclear palsy
Satoshi Tanikawa, Takeru Kuwabara, … Gábor Géza Kovács·bioRxiv·Jan 28, 2026